Corvidane
A novel approach to treating cardiovascular and liver diseases
4 employees · est. 2014 · The Netherlands
Oyster Point Pharma
Commercial-stage biopharmaceutical company focused on pharmaceutical therapies to treat ophthalmic diseases.
88 employees · est. 2015 · Princeton, United States
Corvidane is the older company (2014 vs 2015); Oyster Point Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Corvidane | Oyster Point Pharma |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2015 |
| Headquarters | ||
| Headquarters | The Netherlands | Princeton, United States |
| Employees | ||
| Employees | 4 | 88 larger |
| Industry | ||
| Industry | Health and Wellness, Manufacturing, Pharmaceutical | Biopharma, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $235.80M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardiovascular Diseases, Liver Diseases, Metabolic Diseases, Inflammatory Diseases, Atherosclerosis, MASH, Drug Development, Biopharmaceutical, Oral Medications, Treatment Therapies, Innovative Treatments, Pharmaceutical Research, Medical Innovation, Healthcare Advancements | Biopharmaceutical Company, Ophthalmic Diseases, Clinical-stage, Pharmaceutical Therapies, Ocular Surface Diseases, OC-01, Nicotinic Acetylcholine Receptor, Dry Eye Disease, Tear Film Homeostasis, Lacrimal Functional Unit, Pharmaceutical Development, Innovative Treatments, Nasal Spray, Medical Research, Healthcare Industry |
| Website | ||
| Website | corvidane.com | oysterpointrx.com |
About Corvidane
Corvidane is a biotech startup with a novel approach to treating cardiovascular and liver diseases. Founded in 2014, the company is focused on developing Corvida™ for the treatment of atherosclerosis and metabolic associated fatty liver disease (MASH). Corvidane's innovative approach targets atheros...
About Oyster Point Pharma
Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. Founded in 2015 and headquartered in the United States, the company has garnered notable attention...
We will tell you when either one moves
BounceWatch watches Corvidane and Oyster Point Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Corvidane and Oyster Point Pharma — by email.
Frequently Asked Questions
Compare Corvidane with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Corvidane on 14 Sep 2024, and Oyster Point Pharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.